Close
ACHEMA MIDDLE EAST 2026
5th LNP Formulation & Process Development Summit

Drug Development

      Ascletis Received Approval of Clinical Trials in HBV Patients for ASC22

      FDA Approvals
      Ascletis Pharma Inc announces the approval for ASC22 to conduct clinical trials in chronic hepatitis B patients in China from China's National Medical Products...

      Grey Wolf Therapeutics completes £2.5 million Series A2 financing to accelerate development of therapies targeting ERAP2

      Drug Development
      Grey Wolf Therapeutics, a drug discovery biotechnology company focused on developing first-in-class therapies for immuno-oncology (IO), announces it has completed a £2.5 million ($3.3...

      Fycompa for Adjunctive treatment of Partial Onset Seizures launched in China

      Drug Development
      Eisai Co., Ltd announced hat it has launched the in-house discovered and developed antiepileptic drug (AED) Fycompa®, generic name perampanel) for use in adjunctive...

      Amgen Commences Strategic Collaboration With BeiGene to Expand Oncology Presence in China

      News
      Amgen announced the successful closing of the transaction to enter into a strategic collaboration with BeiGene that will significantly accelerate Amgen's plans to expand...

      Lokelma approved in China for the treatment of adult patients with hyperkalaemia

      FDA Approvals
      AstraZeneca’s Lokelma has been approved in China for the treatment of adult patients with hyperkalaemia (elevated levels of potassium in the blood). The approval by...

      Syneos Health Insights Hub Releases 2020 Health Trends, Identifying Critical Shifts Impacting Drug Development and Commercialization

      Drug Development
      The Syneos Health® Insights Hub, a dynamic destination for what’s next thinking and future-focused insights, released 2020 Health Trends: Changing Lives and Life Sciences....

      Merck Establishes Strategic Oncology Collaboration with Taiho and Astex

      Manufacturing
      Merck known as MSD outside the United States and Canada, announced an exclusive worldwide research collaboration and license agreement with Taiho Pharmaceutical Co, Ltd.,...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

      Resources

      Advertise

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.